BioScrip Earnings: What Investors Should Watch

Bioscrip (NASDAQ:BIOS) will report earnings after markets close on Wednesday, May 8th. BioScrip, Inc. is a pharmacy benefit management and specialty pharmaceutical organization that partners with managed care organizations and healthcare providers to control prescription drug costs. The Company provides pharmacy benefit products and services and mail order pharmacy services, and is the fulfillment center for online retailers offering prescription and OTC products.

Here is your Cheat Sheet to Bioscrip Earnings:

Earnings Expectations: Analysts expect earnings of $0.02 per share on revenues of $189.36 million. Currently, the company’s P/E ratio stands at 11.85.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.06 to a profit $0.05. For the current year, the average estimate is a profit of $0.25, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Bioscrip has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 1,402 1,330 430.71 554.51 662.64
Diluted EPS ($) -1.93 1.36 -1.37 0.14 1.15

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 158.26 155.63 155.90 170.36 180.74
Diluted EPS ($) 0.1220 -0.05 1.29 -0.20 0.1262

Past Performance:
Bioscrip has missed analyst estimates 3 times in the past four quarters. Shareholders could expect a bust if the company misses estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]